サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641788

内視鏡消毒用化学薬品の世界市場：製品タイプ別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年

Endoscope Disinfection Chemicals Market By Product Type (Glutaraldehyde, Peracetic Acid, Others) , By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 239 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
内視鏡消毒用化学薬品の世界市場：製品タイプ別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年
出版日: 2024年11月01日
発行: Allied Market Research
ページ情報: 英文 239 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

内視鏡消毒用化学薬品市場

Endoscope Disinfection Chemicals Market-IMG1

内視鏡消毒用化学薬品市場は、2023年に8億米ドルとなり、2024年から2033年にかけてCAGR4.2%で成長し、2033年までには12億米ドルに達すると予測されています。

内視鏡は、診断や外科手術の際に中空臓器の内部を可視化するために使用される管状の医療機器です。内視鏡は体液に直接触れるため、その消毒は非常に重要なプロセスです。医療器具を消毒するために使用される化学薬品は、その消毒レベルに基づいて、高水準消毒薬、中水準消毒薬、低水準消毒薬に分類されます。一般的に使用される内視鏡消毒用化学薬品の例としては、グルタルアルデヒド、過酢酸、ヨードホス、第四級アンモニウム化合物などがあります。

内視鏡検査や低侵襲手術の急激な増加により、医療機器の品質や機能性を維持しながら滅菌する薬品に対する需要が高まっています。そのため、内視鏡の繰り返し使用は一貫した消毒につながり、内視鏡消毒用化学薬品品市場の成長を増大させています。さらに、病院やその他のヘルスケア施設は感染性微生物の拠点であり、これが市場の主要促進要因となっています。これは、医療機器、特に患者の身体に直接接触する医療機器の適切な消毒が、院内感染の予防に極めて重要であるという事実に起因しています。最近では、内視鏡を数分以内で消毒する新しい製剤の開発が目立っています。メーカーは、内視鏡を滅菌し、ワークフローの効率を向上させるために、自動処理装置とともに使用されるいくつかの高レベル消毒剤を組み込んでいます。

しかし、これらの化学薬品の長期使用に伴う健康被害や環境への影響に関する懸念が市場開拓の妨げとなっています。逆に、化学的消毒と他の滅菌方法の組み合わせは、内視鏡消毒用化学薬品市場に新たな道を開くことになります。例えば、蒸気滅菌装置のメーカーであるMatachanaによると、酸化エチレン、過酸化水素プラズマ、低温蒸気＆ホルムアルデヒドの利点をブレンドすることで、内視鏡の深部消毒が可能になるといいます。

セグメントレビュー

内視鏡消毒用化学薬品市場は、製品タイプ、エンドユーザー、地域に区分されます。製品タイプ別では、市場はグルタルアルデヒド、過酢酸、その他に分けられます。エンドユーザー別では、病院・クリニック、外来手術センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで分析されます。

主要な調査結果

製品タイプ別では、グルタルアルデヒドセグメントが予測期間中に市場を独占すると予測されます。

エンドユーザー別では、病院・クリニックセグメントが2024年から2033年にかけて最も高いシェアになると予測されています。

地域別では、北米が2033年までに最も高い収益を上げると予測されています。

本レポートのカスタマイズが可能です（追加費用とスケジュールがあります。）

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 平均販売価格分析／価格帯分析
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な投資機会
    • 主要な成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 内視鏡消毒用化学薬品市場：製品タイプ別

  • 市場概要
  • グルタルアルデヒド
  • 過酢酸
  • その他

第5章 内視鏡消毒用化学薬品市場：エンドユーザー別

  • 市場概要
  • 病院・診療所
  • 外来手術センター
  • その他

第6章 内視鏡消毒用化学薬品市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の内視鏡消毒用化学薬品市場
    • カナダの内視鏡消毒用化学薬品市場
    • メキシコの内視鏡消毒用化学薬品市場
  • 欧州
    • 主要な市場動向と機会
    • ドイツの内視鏡消毒用化学薬品市場
    • フランスの内視鏡消毒用化学薬品市場
    • 英国の内視鏡消毒用化学薬品市場
    • イタリアの内視鏡消毒用化学薬品市場
    • スペインの内視鏡消毒用化学薬品市場
    • その他欧州の内視鏡消毒用化学薬品市場
  • アジア太平洋
    • 主要な市場動向と機会
    • 日本の内視鏡消毒用化学薬品市場
    • 中国の内視鏡消毒用化学薬品市場
    • インドの内視鏡消毒用化学薬品市場
    • オーストラリア内視鏡消毒用化学薬品市場
    • 韓国の内視鏡消毒用化学薬品市場
    • その他アジア太平洋の内視鏡消毒用化学薬品市場
  • ラテンアメリカ・中東・アフリカ
    • 主要な市場動向と機会
    • ブラジルの内視鏡消毒用化学薬品市場
    • サウジアラビアの内視鏡消毒用化学薬品市場
    • 南アフリカの内視鏡消毒用化学薬品市場
    • その他のラテンアメリカ、中東・アフリカの内視鏡消毒用化学薬品市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第8章 企業プロファイル

  • STERIS
  • Olympus Corporation
  • Getinge AB
  • Borer Chemie AG
  • Micro-Scientific, LLC.
  • Medalkan
  • Cantel Medical Corp.
  • Ecolab
  • Fortive Corporation
  • SteelcoBelimed AG
目次
Product Code: A324000

Endoscope Disinfection Chemicals Market

Endoscope Disinfection Chemicals Market - IMG1

The endoscope disinfection chemicals market was valued at $0.8 billion in 2023 and is projected to reach $1.2 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033.

An endoscope is a tubular medical device used to visualize the interior of hollow organs during diagnostic and surgical procedures. The disinfection of these devices is a significantly important process as they come in direct contact with the body fluids. The chemicals used to disinfect the medical device are categorized on the basis of their disinfection levels into high-level, intermediate-level, and low-level disinfectants. Examples of commonly used endoscope disinfection chemicals include glutaraldehyde, peracetic acid, iodophors, and quaternary ammonium compounds.

Exponential increase in the number of endoscopies and minimally invasive surgeries has boosted the demand for chemicals that sterilize medical equipment while maintaining their quality and functionality. Therefore, the recurrent use of endoscopes leads to consistent disinfection, which augments the growth of the endoscope disinfection chemicals market. Furthermore, hospitals and other healthcare facilities are a hub for infectious microorganisms, and this acts as a key driver of the market. This is attributed to the fact that adequate disinfection of medical devices, specifically the ones that come in direct contact with patients' bodies, becomes crucial for the prevention of nosocomial infections. In recent times, the development of new formulations that disinfect endoscopes within minutes is a prominent trend in the market. Manufacturers incorporate several high-level disinfectants, which are used with automated processors to sterilize the endoscopes and improve workflow efficiency.

However, concerns regarding the health hazards and environmental impact associated with the long-term usage of these chemicals hamper the development of the market. On the contrary, the combination of chemical disinfection with other forms of sterilization is poised to open new avenues for the endoscope disinfection chemicals market. For instance, according to Matachana-a manufacturer of steam sterilization equipment-blending the benefits of ethylene oxide, hydrogen peroxide plasma, and low-temperature steam & formaldehyde offers deep disinfection of endoscopes.

Segment Review

The endoscope disinfection chemicals market is segmented into product type, end user, and region. On the basis of product type, the market is divided into glutaraldehyde, peracetic acid, and others. As per end user, it is categorized into hospital & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the glutaraldehyde segment is expected to dominate the market during the forecast period.

As per end user, the hospital & clinics segment is projected to be the highest shareholder from 2024 to 2033.

Region wise, North America is anticipated to be the highest revenue generator by 2033.

Competition Analysis

The leading players operating in the global endoscope disinfection chemicals market include STERIS, Olympus Corporation, Getinge AB, Borer Chemie AG, Micro-Scientific, LLC, Medalkan, Cantel Medical Corp., Ecolab, Fortive Corporation, and SteelcoBelimed AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Glutaraldehyde
  • Peracetic Acid
  • Others

By End User

  • Hospital and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • STERIS
    • Olympus Corporation
    • Getinge AB
    • Borer Chemie AG
    • Micro-Scientific, LLC.
    • Medalkan
    • Cantel Medical Corp.
    • Ecolab
    • Fortive Corporation
    • SteelcoBelimed AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Glutaraldehyde
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Peracetic Acid
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospital And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Product Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Endoscope Disinfection Chemicals Market
      • 6.2.5.1. Market Size and Forecast, By Product Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Endoscope Disinfection Chemicals Market
      • 6.2.6.1. Market Size and Forecast, By Product Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Endoscope Disinfection Chemicals Market
      • 6.2.7.1. Market Size and Forecast, By Product Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Product Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Endoscope Disinfection Chemicals Market
      • 6.3.5.1. Market Size and Forecast, By Product Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Endoscope Disinfection Chemicals Market
      • 6.3.6.1. Market Size and Forecast, By Product Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Endoscope Disinfection Chemicals Market
      • 6.3.7.1. Market Size and Forecast, By Product Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Endoscope Disinfection Chemicals Market
      • 6.3.8.1. Market Size and Forecast, By Product Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Endoscope Disinfection Chemicals Market
      • 6.3.9.1. Market Size and Forecast, By Product Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest Of Europe Endoscope Disinfection Chemicals Market
      • 6.3.10.1. Market Size and Forecast, By Product Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Product Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Endoscope Disinfection Chemicals Market
      • 6.4.5.1. Market Size and Forecast, By Product Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Endoscope Disinfection Chemicals Market
      • 6.4.6.1. Market Size and Forecast, By Product Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Endoscope Disinfection Chemicals Market
      • 6.4.7.1. Market Size and Forecast, By Product Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Endoscope Disinfection Chemicals Market
      • 6.4.8.1. Market Size and Forecast, By Product Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Endoscope Disinfection Chemicals Market
      • 6.4.9.1. Market Size and Forecast, By Product Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Endoscope Disinfection Chemicals Market
      • 6.4.10.1. Market Size and Forecast, By Product Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Product Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Endoscope Disinfection Chemicals Market
      • 6.5.5.1. Market Size and Forecast, By Product Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Endoscope Disinfection Chemicals Market
      • 6.5.6.1. Market Size and Forecast, By Product Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Endoscope Disinfection Chemicals Market
      • 6.5.7.1. Market Size and Forecast, By Product Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Endoscope Disinfection Chemicals Market
      • 6.5.8.1. Market Size and Forecast, By Product Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping Of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. STERIS
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Olympus Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Getinge AB
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Borer Chemie AG
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Micro-Scientific, LLC.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medalkan
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Cantel Medical Corp.
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Ecolab
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Fortive Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. SteelcoBelimed AG
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments